ArticleJACC. Asia2026
Association Between Cardiac Acceleration Capacity and Susceptibility to Vasovagal Syncope: Autonomic Dysregulation in Vasovagal Syncope.
Article in JACC. Asia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVasovagal syncope (VVS) might be associated with alterations in vagal activity. Cardiac acceleration capacity (AC) is a novel index related to autonomic modulation. It remains unknown whether AC could be used to assess vagal tone and differentiate VVS patients.
objectivesThis study aimed to investigate the association between AC and VVS, and evaluate the capability of AC to identify VVS susceptibility.
methodsIn this observational study, 204 VVS patients (41.2 ± 16.9 years, 40.2% [82 of 204] men) were included, of whom 87.3% (178 of 204) VVS patients had positive responses to tilt-table testing, and 116 asymptomatic individuals were included as controls. Twenty-four-hour Holter monitoring was performed for all participants. Multivariate logistic regression analysis and receiver-operating characteristic curves were performed for heart rate variability metrics.
resultsVVS patients exhibited significantly higher AC than control subjects (8.81 ± 2.21 ms vs 5.89 ± 1.27 ms; P < 0.001). AC correlated with deceleration capacity (VVS: r = 0.90 [95% CI: 0.83-0.96]; controls: r = 0.92 [95% CI: 0.85-1.00]) and other vagal-dominant heart rate variability metrics. In multivariate models, increased AC was significantly associated with an elevated risk of VVS (adjusted OR: 3.54 [95% CI: 2.55-4.91]). Daytime AC showed strong discriminative power for VVS (area under curve 0.910 [95% CI: 0.879-0.942]), and outperformed nighttime measures in the identification of VVS.
conclusionsHigher AC was observed in VVS patients during the nonsyncopal period, indicative of AC's potential association with vagal modulation. Daytime AC showed superior performance in detecting VVS susceptibility, offering a noninvasive approach to assisting clinical diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.